Solomon Steiner is listed as an executive officer, director, and promoter on 3 SEC Form D filings by 2 issuers between Mar 2020 and Oct 2022: CASS Pharmaceuticals, Inc. (Franklin, TN — other technology — 2020–2022; $1.98M reported sold to 6 investors) and Diakard, Inc. (Franklin, TN — other technology — 2020; $400K reported sold to 4 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter, over about 2 years. Across those companies the filings report $2.38M sold in total.
Listed alongside Stephen McCormack (3 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Solomon. Each name links to their own page.
All 2 issuers belong to the sponsor group Diakard (2 issuers, $2.38M reported sold, 2020–2022).
What this means A sponsor group is one team that sets up a new company for each deal. Diakard has 2 companies on file and $2.38M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Solomon Steiner and found 6 differences, 1 worth asking the sponsor about: Form D filed 63 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.